$13.86
00.00%
Pre-Market: 4:01 PM EDT
15 minutes delayed
Inhibrx Biosciences
INBXNASDAQ
Latest news for Inhibrx Biosciences (NASDAQ:INBX) Stock
Inhibrx Biosciences Stock (NASDAQ: INBX)
Categories: All
Friday, June 07, 2024
Wednesday, June 05, 2024
Friday, May 31, 2024
Friday, May 24, 2024
Wednesday, February 28, 2024
Tuesday, January 23, 2024
- Inhibrx shares are trading higher after the c...
- French Drugmaker Sanofi Agrees To Buy Inhibrx's Candidate For Rare Genetic Indication, For About $2.2B
- Olympic Sponsor Sanofi Makes Major Play In Rare Disease Arena $2.2 Billion Acquisition Of Inhibrx Project
- JMP Securities Downgrades Inhibrx to Market P...
- Inhibrx Sells INBRX-101 To Sanofi For Up To $...
Monday, November 20, 2023
Thursday, November 16, 2023
Thursday, November 09, 2023
Thursday, November 02, 2023
Tuesday, September 19, 2023
Thursday, August 31, 2023
Tuesday, August 29, 2023
- Why NIO Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- PDD Holdings, UP Fintech Holding, Big Lots And Other Big Stocks Moving Higher On Tuesday
- Inhibrx Announces $200M Private Placement Financing; In The PIPE, Co Is Selling An Aggregate Of 3,621,314 Shares Of Its Common Stock At A Price Of $19.35 Per Share
Wednesday, August 23, 2023
Monday, August 07, 2023
Tuesday, May 30, 2023
Wednesday, May 10, 2023
Wednesday, April 26, 2023
Wednesday, March 08, 2023
Tuesday, March 07, 2023
Monday, March 06, 2023
Wednesday, January 04, 2023
Friday, November 18, 2022
Wednesday, November 16, 2022
Tuesday, November 08, 2022
Monday, November 07, 2022
Thursday, October 13, 2022
Wednesday, October 05, 2022
Tuesday, October 04, 2022
- S&P 500 Rises 100 Points; Nasdaq Up 3%
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- Why AeroClean Technologies Shares Are Trading Higher By Around 38%, Here Are 58 Stocks Moving In Tuesday's Mid-Day Session
- Nasdaq Surges 250 Points; Crude Oil Rises Sharply
- US Stocks Open Higher As Dow Jumps 550 Points
- Inhibrx's Experimental Drug For Inherited Disease Capable For Accelerated FDA Approval, Shares Surge
- Inhibrx shares are trading higher after the c...
- Inhibrx Says Based On FDA Discussions, There Is Potential To Pursue Accelerated Approval For INBRX-101